|4Dec 11, 5:03 PM ET

PAPPAJOHN JOHN 4

4 · CANCER GENETICS, INC · Filed Dec 11, 2017

Insider Transaction Report

Form 4
Period: 2017-12-08
Transactions
  • Purchase

    Common Stock, par value $0.0001 per share

    2017-12-08$1.86/sh+150,000$279,0002,781,204 total
Footnotes (1)
  • [F1]1. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.842 to $1.862, inclusive. The reporting person undertakes to provide Cancer Genetics, Inc., any security holder of Cancer Genetics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (1) to this Form 4.

Documents

1 file
  • 4
    wf-form4_151302979599364.xmlPrimary

    FORM 4